Skip to contentS
Syra Health Corp
S
SYRASyra Health Corp Q2 2026 · 10-Q
Revenue$2.39M$2.39M+23.0% vs Q2 2025 Net Income$250.24K$250.24KN/M vs Q2 2025 EPS Diluted$0.02$0.02N/M vs Q2 2025 Gross Profit$1,066,303+41.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
Operating Cash Flowderived-$718,762N/M Margins · derivedGross margin44.5%+5.8 pt vs Q2 2025
Operating margin10.5%+13.8 pt vs Q2 2025
Net margin10.5%+13.7 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end